Overwhelming influx of alliance procurement: orthopaedics and IOLs
On March 9, the "Notice of Selected Results of the Beijing-Tianjin-Hebei "3+N" Alliance Orthopaedic Trauma Medical Consumables with Quantitative Linkage Procurement" was released, involving 17 provinces and districts.
The lowest price was RMB5.51 (shallow threaded screw-2) and the highest was RMB2,059.96 (heel bone intramedullary nail). Unlike the previous volume procurement, this procurement is "volume linked".
In other words, based on the use demand of the procurement body, with reference to the overall price level of the market and comprehensive quality and other factors, the Union of 12 provinces in Henan and other orthopaedic trauma medical consumables with quantity procurement price, through mutual selection between the purchase and sale sides, to determine the selected products, according to the amount of subcontracting, the implementation of the amount of linked procurement.
In September last year, the price of quantity procurement of the 12 provinces of Henan Union was announced. In the end, 71 enterprises of 20,751 products to be selected, an average reduction of 88.65%.
Among them, the price of ordinary bone plate system dropped from an average of about 4,683 yuan to about 606 yuan, an average reduction of 87.05%; the price of locked (universal) compression bone plate system dropped from an average of about 9,360 yuan to about 987 yuan, an average reduction of 89.45%; the price of intramedullary nail system dropped from an average of about 11,687 yuan to about 1,271 yuan, an average reduction of 89.12%.

The same is true of the Beijing-Tianjin-Hebei joint pharmaceutical procurement platform. Also recently released "on the announcement of the Beijing-Tianjin-Hebei "3 + N" Union IOL class medical consumables with the selected results of the joint procurement notice", the same requirements of the procurement cycle, such as other areas with the purchase of the selected price is lower than the selected price of the joint procurement with the volume, the implementation of price linkage.
On November 24, 2021, the Beijing-Tianjin-Hebei "3+N" Alliance started the linked procurement of artificial crystals (except hard crystals).
The procurement body is Beijing, Tianjin, Hebei, Heilongjiang, Jilin, Liaoning, Inner Mongolia, Shanxi, Shandong, Sichuan, Chongqing, Tibet, Henan, Guizhou 14 provinces (autonomous regions and municipalities directly under the Central Government) in 2020 has a record of procurement of IOL medical supplies (including military medical institutions), the procurement cycle for one year.
Looking for chemical products? Let suppliers reach out to you!
2026-06-28
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
-
Treat Acidity: Use medicines with this Pepto Bismol Active Ingredient
-
Biocytogen announces the launch of the 'Nano 100 Project' to develop fully human therapeutic nanobodies against 100+ targets
-
Wantai Biotech 20-valent pneumonia vaccine started clinical trials, how far is domestic substitution?
-
Yiming Cell 'Suspension 293XS Cell Bank' completed DMF filing with the US FDA
-
The phase III clinical study of Junshi Biologics in combination with teripulimab in the treatment of advanced triple-negative breast cancer reached the primary endpoint
-
The next bombshell: 'PD-1 + ADC', Kelun, Hengrui are going to win numbness?
-
L-Rotator Biotech completed its pre-A financing and continued to increase its investment in the CGT field
-
Hainan to promote drug import facilitation
-
Enable the 'export of EU APIcertification documents' and 'pharmaceutical export salescertificate' electronic proof
Recommend Reading
-
AstraZeneca Rare Disease Drug Misses Phase 3 Target Hope Shifts to Subgroup Data
-
Over 22,000 New Cases in India AstraZeneca Gets CDSCO Green Light for Muscle-Invasive Bladder Cancer Drug
-
Trump Warns of 200 Percent Tariffs on Pharma Companies by August 1 India Trade Deal Among Top Priorities
-
Emcure Seals Exclusive Deal for Sanofi’s Oral Diabetes Brands Millions of Indian Patients to Benefit
-
60 Percent Workforce Held by Top 10 Firms! China’s TCM Industry Faces Fierce Reshuffle as Private Leaders Expand Fast
-
Elkem Launches Innovative Formulations with Low-Cyclic Silicone Ingredients
-
Titan Technology Makes Bold Move with 55.85 Million Yuan Acquisition of UK Biochemical Firm ASL — What's Behind the Deal?
-
Kemira to Expand Drinking Water Treatment Portfolio with New ACH Production Line
-
ECHEMI High Quality Inquiries (21-25 Jul)
-
Raw Materials Soften, Consumption Sluggish—PC Prices Fall from High Levels